| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/13/1993 | WO1993009130A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 05/13/1993 | WO1993009124A1 Photosensitizers |
| 05/13/1993 | WO1993009119A1 Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines |
| 05/13/1993 | WO1993009117A1 Immunostimulating swainsonine analogs |
| 05/13/1993 | WO1993009110A1 Compound dc8118 |
| 05/13/1993 | WO1993009097A1 Collagenase inhibitor |
| 05/13/1993 | WO1993009093A1 Vitamin d amide derivatives |
| 05/13/1993 | WO1993009089A1 Bistriazenes as chemotherapeutic agents |
| 05/13/1993 | WO1993008821A1 Side effect inhibitor for cancer therapy |
| 05/13/1993 | WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008794A1 Pharmaceutical products for curing tumorous diseases and process for preparing same |
| 05/13/1993 | CA2123104A1 Collagenase inhibitor |
| 05/13/1993 | CA2123098A1 Immunostimulating swainsonine analogs |
| 05/13/1993 | CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | CA2121249A1 Antiviral 2-ethyl-1h-imidazo¬4,5-c|quinolin-4-amines |
| 05/12/1993 | EP0541486A1 Polycyclic conjugates |
| 05/12/1993 | EP0541404A2 Pyrimido(4,5-g)quinazoline derivatives with anti-tumour activity |
| 05/12/1993 | EP0541322A1 1-Alkyl-2-acyl-1,2-disulfonylhydrazines with antineoplastic activity |
| 05/12/1993 | EP0540859A1 Anthracycline prodrugs |
| 05/12/1993 | EP0540782A1 Use of analogues of polyisoprenyl pyrophosphate for inhibiting protein isoprenylation |
| 05/12/1993 | EP0540767A1 Treatment of lyso paf-mediated diseases with paf antagonists and procedure for determining their efficacy |
| 05/12/1993 | EP0540649A1 Method for hydroxylation of a cyclic or acyclic methylene radical in the allylic position, pharmaceutical composition containing hydroxycholesterol derivatives and utilisation of such compositions for the preparation of drugs |
| 05/12/1993 | EP0538268A4 Targeted protection from cytotoxins |
| 05/12/1993 | EP0525054A4 Modified heparin binding growth factors |
| 05/12/1993 | EP0500739A4 Herbal treatment of malignancy |
| 05/12/1993 | CN1071950A Antitumor antibiotic |
| 05/12/1993 | CN1071929A Process for producing sugar phosphates and sulfonates of epipodophylotoxin glucosides |
| 05/12/1993 | CN1071912A Cytotoxic bicyclo (7,3,1) tridec-4-ene-2,6-diyne compounds and process for preparation thereof |
| 05/12/1993 | CN1071836A Pharmaceutical products for curing tumourous diseases and process for preparing same |
| 05/12/1993 | CN1071834A Composition and method for treating cancer |
| 05/11/1993 | US5210237 Vitamin d3 analogues |
| 05/11/1993 | US5210097 Xanthocillin x monomethyl ether derivative and antitumor agent containing the same |
| 05/11/1993 | US5210078 Trifluoromethyl analogs of fucose and uses thereof |
| 05/11/1993 | CA1317587C Esters |
| 05/09/1993 | WO1993009239A1 Adeno-associated virus-2 basal vectors |
| 05/09/1993 | CA2082297A1 Synthesis and elucidation of pyrimido [4, 5-g] quinazoline derivatives |
| 05/09/1993 | CA2082037A1 1-alkyl-2-acyl-1,2-disulfonylhydrazines |
| 05/08/1993 | CA2082216A1 Polycyclic conjugates |
| 05/06/1993 | DE4232465A1 Arzneimittel, ihre verwendung und verfahren zu deren herstellung Drugs, their use and processes for their preparation |
| 05/05/1993 | EP0540421A1 Indigestible dextrin |
| 05/05/1993 | EP0540099A1 Water soluble camptothecin derivatives |
| 05/05/1993 | EP0539525A1 Vitaletheine and use in cell culture and therapy |
| 05/05/1993 | EP0486526A4 Tumour necrosis factor binding ligands |
| 05/05/1993 | CN1071582A Leukemia converted from aplastic anemia |
| 05/04/1993 | US5208253 Antiinflammatory agents |
| 05/04/1993 | CA1317292C Derivatives of (1-hydroxy-2-piperidylalkyl)-indol-2-ones, 2-quinolinones, 2-benzo[b]azapinones, benzimidazol-2-ones, and quinazolin-2-ones, their preparation and their applicationin therapeutics |
| 05/04/1993 | CA1317290C 4'-deshydroxyepipodophyllotoxin glucosides: synthesis and use |
| 04/30/1993 | CA2081580A1 Water soluble camptothecin derivatives |
| 04/30/1993 | CA2081510A1 Alkaloids and processes for their production |
| 04/29/1993 | WO1993008273A1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
| 04/29/1993 | WO1993008267A1 Cell cycle controlling compositions and methods of using same |
| 04/29/1993 | WO1993008215A1 Secreted mac-2-binding glycoprotein |
| 04/29/1993 | WO1993008210A1 Vascular permeability factor targeted compounds |
| 04/29/1993 | WO1993008120A1 2-aminopropan-1,3-diol chemotherapeutic agents |
| 04/29/1993 | WO1993007906A1 Lymphokine gene therapy of cancer |
| 04/29/1993 | WO1993007868A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-tumor and anti-retroviral agents |
| 04/29/1993 | CA2121900A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-tumor and anti-retroviral agents |
| 04/29/1993 | CA2121127A1 Lymphokine gene therapy of cancer |
| 04/29/1993 | CA2120234A1 2-aminopropan-1,3-diol chemotherapeutic agents |
| 04/28/1993 | EP0539326A2 Bis (phenyl)ethane derivatives |
| 04/28/1993 | EP0538898A2 Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof |
| 04/28/1993 | EP0538858A1 Improved lyophilized ifosfamide compositions |
| 04/28/1993 | EP0538810A2 Pharmaceutical compositions comprising IL-6 |
| 04/28/1993 | EP0538781A2 Antitumor antibiotic from actinomadura |
| 04/28/1993 | EP0538517A1 Novel organo-tin compounds having anti-tumour activity and anti-tumour compositions |
| 04/28/1993 | EP0538463A1 Novel biologically active peptide compositions and uses therefor |
| 04/28/1993 | EP0538436A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them |
| 04/28/1993 | EP0538402A1 Method of preparing a radioactive rhenium complex solution |
| 04/28/1993 | EP0538399A1 Cyclic cell adhesion modulation compounds |
| 04/28/1993 | EP0538340A1 Therapeutic use of piperidine-2,6-diones |
| 04/28/1993 | EP0538330A1 Beta-alethine use in cell culture and therapy. |
| 04/28/1993 | EP0538300A1 O-glycosylated ifn-alpha. |
| 04/28/1993 | EP0538268A1 Targeted protection from cytotoxins |
| 04/28/1993 | EP0485530A4 Tgf--g(b) protein compositions for inhibition of cell proliferation |
| 04/28/1993 | EP0386146B1 Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy |
| 04/28/1993 | CN1071432A Crystalline etoposide 4'-phosphate diethanelate |
| 04/28/1993 | CN1071418A Benzo (f) quinolinones |
| 04/27/1993 | US5206377 Melatonin antagonist |
| 04/27/1993 | US5206351 Process for the preparation of 2-amino (2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenine |
| 04/27/1993 | US5206343 Oligopetides with cyclic proline-analogous amino acids |
| 04/27/1993 | US5206256 Aromatase inhibitors |
| 04/27/1993 | US5206250 Bis-naphthalimides containing amide and thioamide linkers as anticancer agents |
| 04/27/1993 | US5206249 Bis-naphthalimides containing amino-acid derived linkers as anticancer agents |
| 04/27/1993 | US5206237 Benzodiazepine analogs |
| 04/27/1993 | US5206234 Benzolactam analogs as antagonists of cck |
| 04/27/1993 | US5206230 Antitumor agents |
| 04/27/1993 | US5206229 Inhibit cell proliferation, antiinflammatory, treating imbalance of immune system |
| 04/27/1993 | CA1316928C Alpha-heterocycle substituted tolunitriles |
| 04/27/1993 | CA1316914C Process for the preparation of methylene derivatives of androsta-1,4-diene-3,17-dione |
| 04/27/1993 | CA1316848C Monoclonal antibody recognizing un-natural ganglioside gd |
| 04/27/1993 | CA1316828C Compounds having anti-metastatic and/or anti-inflammatory activity |
| 04/26/1993 | CA2081007A1 Cytotoxic bicyclo¬7.3.1|tridec-4-ene-2, 6-diyne compounds and process for the preparation thereof |
| 04/24/1993 | CA2081061A1 Improved lyophilized ifosfamide compositions |
| 04/23/1993 | CA2080873A1 Antitumor antibiotic |
| 04/23/1993 | CA2079539A1 Organotin compounds having anti-tumour activity and anti-tumour compositions |
| 04/21/1993 | EP0538193A2 Condensed cycloaliphatir-amidino-hydrazon salts as S-adenosylmethionin decarboxylase inhibitors |
| 04/21/1993 | EP0538192A1 New 17-beta-substituted aza-androstanderivatives |
| 04/21/1993 | EP0537949A1 Antiproliferative derivatives of 4H-naphtho 1,2-b pyran |
| 04/21/1993 | EP0537696A1 Heterobiaryl derivatives, medicines containing those compounds and process for their preparation |